15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $19M | $1M | 61.9% | 6.1% | — | — | $5M |
| 2024 | $14M | $74000 | 61.6% | 0.0% | -$547000 | — | $4M |
| 2023 | $14M | -$2M | 59.0% | -11.2% | $752000 | — | $4M |
| 2022 | $10M | — | 47.4% | -43.5% | -$3M | $71000 | $4M |
| 2021 | $10M | -$4M | 55.1% | -31.8% | -$1M | $343000 | $7M |
| 2020 | $9M | -$5M | 57.4% | -49.9% | -$7M | $593000 | $8M |
| 2019 | $10M | -$3M | 58.9% | -30.5% | -$2M | $824000 | $4M |
| 2018 | $6M | -$3M | 56.3% | -53.0% | — | $1M | — |
| 2017 | $4M | -$809000 | 60.2% | -58.4% | — | — | — |
| 2016 | — | -$3M | — | — | — | — | — |
| 2015 | — | -$3M | — | — | — | — | — |
| 2014 | — | -$7M | — | — | — | — | — |
| 2013 | — | $1M | — | — | — | — | — |
| 2012 | — | -$7M | — | — | — | — | — |
| 2011 | — | -$7M | — | — | — | — | — |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $5M | $140000 | 57.4% | 1.9% | — | — | $4M |
| Dec '25 | $5M | $62000 | 58.4% | 0.4% | — | — | $5M |
| Sep '25 | $5M | $337000 | 61.2% | 6.6% | — | — | $5M |
| Jun '25 | $4M | $237000 | 63.2% | 5.6% | — | — | $5M |
| Mar '25 | $5M | $558000 | 64.7% | 11.6% | — | — | $4M |
| Dec '24 | $4M | $349000 | 64.0% | 8.2% | $1M | — | $4M |
| Sep '24 | $4M | $183000 | 61.1% | 5.9% | -$623000 | — | $2M |
| Jun '24 | $3M | -$289000 | 58.8% | -9.7% | — | — | $3M |
| Mar '24 | $4M | -$169000 | 62.1% | -5.7% | — | — | $4M |
| Dec '23 | $3M | -$654000 | 62.1% | -19.9% | — | — | $4M |
| Sep '23 | $4M | -$182000 | 58.6% | -5.4% | — | — | $5M |
| Jun '23 | $4M | -$433000 | 58.6% | -12.3% | — | — | $4M |
| Mar '23 | $4M | -$306000 | 57.1% | -8.3% | — | — | $4M |
| Dec '22 | $3M | — | 59.0% | -27.1% | -$195000 | $71000 | $4M |
| Sep '22 | $2M | -$3M | 31.6% | -53.2% | -$170000 | $141000 | $4M |
| Jun '22 | $3M | -$1M | 48.9% | -28.6% | -$1M | $210000 | $4M |
| Mar '22 | $2M | -$2M | 48.8% | -71.7% | -$2M | $277000 | $5M |
| Dec '21 | $3M | -$1M | 54.2% | -26.6% | -$335000 | $343000 | $7M |
| Sep '21 | $3M | -$1M | 52.8% | -31.1% | -$923000 | $407000 | $7M |
| Jun '21 | $2M | -$1M | 56.3% | -49.3% | -$117000 | $470000 | $8M |
How the market has priced NEPH against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, NEPHROS INC's revenue has grown 17.0% per year. These are computed facts, not advice.
As of FY2025, NEPHROS INC reported — of total debt against $5M of cash; operating income covered interest expense 1146×.
In FY2025, gross margin was 61.9%, operating margin 6.1%, and net margin 6.4%.
As of Jun '26, NEPHROS INC traded at a price-to-earnings ratio of about 29.9× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.